Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population (Q38492975)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2010

Language	Label	Description	Also known as
English	Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population	scientific article published on March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

author name string

Yoosook Joung

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Chun-Hyung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jisook Moon

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Won-Seok Jang

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Jaewon Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Dongwon Shin

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Soonyoung Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kwang-Soo Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

153B

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

691-694

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Support for association between ADHD and two candidate genes: NET1 and DRD1.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Hyperactive boys almost grown up. I. Psychiatric status

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

A previously undescribed intron and extensive 5' upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

An E-box motif residing in the exon/intron 1 junction regulates both transcriptional activation and splicing of the human norepinephrine transporter gene

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Persistence of hyperactivity symptoms from childhood to adolescence and associated outcomes

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

The hyperactive child syndrome: peripheral sympathetic nervous system function and the effect of d-amphetamine

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

The neuropsychopharmacology of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.B.31012

21 January 2018

Identifiers

10.1002/AJMG.B.31012

1 reference

https://api.fatcat.wiki/v0/release/rdk6w2d2ebfqtjyf77ypfa7zly

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_rdk6w2d2ebfqtjyf77ypfa7zly

1 reference

https://api.fatcat.wiki/v0/release/rdk6w2d2ebfqtjyf77ypfa7zly

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/rdk6w2d2ebfqtjyf77ypfa7zly

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38492975&oldid=2172644497"